APA (7th ed.) Citation

R, G., R, F., I, H., A, A., R, L., B, A., . . . J, B. (2025). Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: A multicenter real-world cohort study. Intestinal research, 23(3), 347. https://doi.org/10.5217/ir.2024.00127

Chicago Style (17th ed.) Citation

R, Gilmore, et al. "Upadacitinib Induction Is Effective and Safe in Ulcerative Colitis Patients Including Those with Prior Exposure to Tofacitinib: A Multicenter Real-world Cohort Study." Intestinal Research 23, no. 3 (2025): 347. https://doi.org/10.5217/ir.2024.00127.

MLA (9th ed.) Citation

R, Gilmore, et al. "Upadacitinib Induction Is Effective and Safe in Ulcerative Colitis Patients Including Those with Prior Exposure to Tofacitinib: A Multicenter Real-world Cohort Study." Intestinal Research, vol. 23, no. 3, 2025, p. 347, https://doi.org/10.5217/ir.2024.00127.